Related Experiment Video
Updated: Jul 13, 2026
14:53
Techniques for the Evolution of Robust Pentose-fermenting Yeast for Bioconversion of Lignocellulose to Ethanol
Published on: October 24, 2016
Sucrose and sucrose substitutes. Industrial considerations
Pharmacology and Therapeutics in Dentistry
|January 1, 1978
Summary
Food manufacturers face challenges in reducing sugar content, needing bulking agents alongside artificial sweeteners. Successful sugarless products highlight opportunities but also complexities in claims, costs, and regulations.
Area of Science:
- Food Science
- Nutritional Science
- Regulatory Affairs
Background:
- Reducing sugar content in foods is a significant challenge for manufacturers.
- The demand for sugar substitutes is driven by consumer health consciousness and regulatory pressures.
- Current sugar reduction strategies often require both artificial sweeteners and functional bulking agents.
Purpose of the Study:
- To explore the challenges and opportunities for food manufacturers in reducing sugar content.
- To differentiate the roles of artificial sweeteners and bulking agents in sugar reduction.
- To discuss the implications of sugar substitution on product claims, nomenclature, safety, and costs.
Main Methods:
- Analysis of the food manufacturing perspective on sugar reduction.
- Review of market success for sugarless confections (e.g., sorbitol usage).
- Discussion of regulatory and consumer pressures influencing food product development.
Main Results:
- The market for sugarless confections is substantial, with significant use of bulking agents like sorbitol.
- Widespread sugar substitution faces hurdles related to product claims, nomenclature, and the high cost of safety and dental efficacy validation.
- Competitive pressures from consumers and regulatory bodies are increasing.
Conclusions:
- Effective sugar reduction requires technological solutions beyond artificial sweeteners, focusing on bulking agents with sugar-like properties.
- The food industry faces significant economic and regulatory challenges in adopting widespread sugar substitution.
- An appeal is made for the dental profession to proactively guide the food industry towards developing healthier food options.
Related Concept Videos
01:44What are Carbohydrates?
Overview
01:10Sugars as Energy Storage Molecules
Sugar (a simple carbohydrate) metabolism (chemical reactions) is a classic example of the many cellular processes that use and produce energy. Living things consume sugar as a major energy source because sugar molecules have considerable energy stored within their bonds. Consumed carbohydrates have their origins in photosynthesizing organisms like plants. During photosynthesis, plants use the energy of sunlight to convert carbon dioxide gas into sugar molecules, like glucose. Because this...
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:10Sugars as Energy Storage Molecules
Sugar (a simple carbohydrate) metabolism (chemical reactions) is a classic example of the many cellular processes that use and produce energy. Living things consume sugar as a major energy source because sugar molecules have considerable energy stored within their bonds. Consumed carbohydrates have their origins in photosynthesizing organisms like plants. During photosynthesis, plants use the energy of sunlight to convert carbon dioxide gas into sugar molecules, like glucose. Because this...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...